Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...

For years, Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their ...

When Martin Kampmann, PhD, set out to explore the workings of the human brain, he was captivated by its greatest mystery: how a network of cells could produce something as intangible as thoughts, ...

In a groundbreaking fusion of artificial intelligence and gene editing, researchers are leveraging machine learning to enhance CRISPR technology’s precision and efficiency. This integration is opening ...

Share on Pinterest Researchers are hoping the CRISPR gene-splicing technology can be used to treat dementia and ALS. Getty Images Researchers are looking at the CRISPR gene-splicing technology to see ...

The concept of CRISPR gene-editing is still quite young. Although the discovery of CRISPRs themselves—repeating DNA sequences present in single-celled organisms, such as bacteria—can be traced back to ...

In January 2020, CRISPR startup Sherlock Biosciences was in the middle of working on CRISPR-based tests that could deliver lab quality testing at home for common illnesses like flu or sexually ...

CRISPR excites ambition. Just consider a few CRISPR applications: gene drives (showing promise as a way to prevent malaria); ex vivo and in vivo gene therapies (entering clinical trials); and ...

May 12 (Reuters) - The University of California and the University of Vienna on Monday convinced a U.S. appeals court to revive their bid for patent rights to groundbreaking CRISPR gene-editing ...

The Situation: Recent developments in the patent landscape of Clustered Regularly Interspaced Short Palindromic Repeats ("CRISPR") gene-editing technology are increasingly impacting global food ...

CRISPR technology, targeting genetic diseases and cancer, may bring major biotech stock growth. CRISPR Therapeutics and Intellia show progress with clinical trials and big pharma partnerships.